86-21-64556180 ib

MI

CAT # Khoom npe Kev piav qhia
PEB 3218 BMS-955176 GSK3532795, tseem hu ua BMS-955176, yog lub zog, qhov ncauj nquag, thib ob tiam HIV-1 maturation inhibitor (MI) uas tau nce mus txog theem IIb kev sim tshuaj. GSK3532795 sib txuas dav dav ntawm cov kab mob polymorphic (EC50)<15 nM mus rau lub vaj huam sib luag ntawm cov neeg sawv cev ntawm ntau hom polymorphisms ntawm 96.5% HIV-1 subtype B tus kab mob) nrog rau cov tshuaj pharmacokinetic profile nyob rau hauv hom preclinical.
ua

Tiv tauj peb

Kev nug

Xov xwm tshiab

  • Sab saum toj 7 trends hauv Pharmaceutical Research Hauv 2018

    Sab saum toj 7 Trends Hauv Pharmaceutical Research Kuv ...

    Nyob rau hauv ib txwm muaj-nce siab los sib tw nyob rau hauv ib tug nyuaj kev lag luam thiab thev naus laus zis ib puag ncig, kws tshuaj thiab biotech tuam txhab uas muag yuav tsum txuas ntxiv innovate nyob rau hauv lawv cov R & D cov kev pab cuam nyob rau hauv ...

  • ARS-1620: Kev cog lus tshiab inhibitor rau KRAS-mutant qog noj ntshav

    ARS-1620: Kev cog lus tshiab inhibitor rau K ...

    Raws li kev tshawb fawb luam tawm hauv Cell, cov kws tshawb fawb tau tsim ib qho inhibitor tshwj xeeb rau KRASG12C hu ua ARS-1602 uas ua rau cov qog nqaij hlav hauv cov nas. "Qhov kev tshawb fawb no muab pov thawj hauv vivo tias mutant KRAS tuaj yeem yog ...

  • AstraZeneca tau txais kev tswj hwm kev txhawb nqa rau cov tshuaj oncology

    AstraZeneca tau txais kev tswj hwm kev txhawb nqa rau ...

    AstraZeneca tau txais kev txhawb nqa ob npaug rau nws cov ntaub ntawv kho mob oncology rau hnub Tuesday, tom qab Asmeskas thiab European cov neeg tswj hwm tau txais kev tswj hwm kev xa tawm rau nws cov tshuaj, thawj kauj ruam ntawm kev pom zoo rau cov tshuaj no. ...

WhatsApp pawg online sib tham!